DK249686A - Ephedrinsalte, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse forbindelser - Google Patents
Ephedrinsalte, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse forbindelser Download PDFInfo
- Publication number
- DK249686A DK249686A DK249686A DK249686A DK249686A DK 249686 A DK249686 A DK 249686A DK 249686 A DK249686 A DK 249686A DK 249686 A DK249686 A DK 249686A DK 249686 A DK249686 A DK 249686A
- Authority
- DK
- Denmark
- Prior art keywords
- salts
- stands
- prevention
- hydrogen
- lower alkyl
- Prior art date
Links
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical class CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 230000002265 prevention Effects 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- 101000862089 Clarkia lewisii Glucose-6-phosphate isomerase, cytosolic 1A Proteins 0.000 abstract 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 abstract 1
- 206010061216 Infarction Diseases 0.000 abstract 1
- 206010067125 Liver injury Diseases 0.000 abstract 1
- 208000018262 Peripheral vascular disease Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 238000004220 aggregation Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 231100000753 hepatic injury Toxicity 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 230000007574 infarction Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- KAQKFAOMNZTLHT-OZUDYXHBSA-N prostaglandin I2 Chemical compound O1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-N 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
- C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Furan Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU852050A HU197733B (en) | 1985-05-29 | 1985-05-29 | Process for producing ephedrin-salts of 7-oxo-prosta-cyclin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK249686D0 DK249686D0 (da) | 1986-05-28 |
| DK249686A true DK249686A (da) | 1986-11-30 |
Family
ID=10957509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK249686A DK249686A (da) | 1985-05-29 | 1986-05-28 | Ephedrinsalte, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse forbindelser |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4735965A (da) |
| EP (1) | EP0205969B1 (da) |
| JP (1) | JPS61277650A (da) |
| KR (1) | KR860009031A (da) |
| CN (1) | CN1010587B (da) |
| AT (1) | ATE71093T1 (da) |
| AU (1) | AU588761B2 (da) |
| CS (1) | CS261894B2 (da) |
| DD (1) | DD244977A5 (da) |
| DE (1) | DE3683192D1 (da) |
| DK (1) | DK249686A (da) |
| ES (1) | ES8706624A1 (da) |
| FI (1) | FI82690C (da) |
| GR (1) | GR861390B (da) |
| HU (1) | HU197733B (da) |
| IL (1) | IL78849A (da) |
| NO (1) | NO171677C (da) |
| NZ (1) | NZ216339A (da) |
| PL (1) | PL148718B1 (da) |
| PT (1) | PT82657B (da) |
| SU (2) | SU1454250A3 (da) |
| YU (1) | YU46169B (da) |
| ZA (1) | ZA863801B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8729153D0 (en) * | 1987-12-14 | 1988-01-27 | Efamol Ltd | Fatty acid compositions |
| HU227157B1 (en) * | 2001-07-30 | 2010-09-28 | Chinoin Gyogyszer Es Vegyeszet | Production of beraprost ester by selective oxidation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU502731B2 (en) * | 1975-09-17 | 1979-08-09 | The Upjohn Company | Prostaglandin analogues |
| IT1088036B (it) * | 1977-11-25 | 1985-06-04 | Erba Carlo Spa | 15-epi-prostaciclina e prostaciclina analoghi |
| US4258199A (en) * | 1978-03-13 | 1981-03-24 | Research Corporation | Method for preparing cyclic ethers and thioethers including oxygen isomers and sulfur analogs of prostacyclin |
| US4330553A (en) * | 1979-11-12 | 1982-05-18 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | 7-Oxo-PGI2 -derivatives and process for the preparation thereof and pharmaceutical compositions containing same |
| HU182012B (en) * | 1979-11-12 | 1983-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 6-substituted-7-oxo-pgi down 1 derivatives |
| DE3035454A1 (de) * | 1980-09-18 | 1982-04-22 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 7-oxoprostacyclinderivate und verfahren zu ihrer herstellung |
| HU191264B (en) * | 1984-01-13 | 1987-01-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | Process for production of derivatives of 7-oxo-prostacyclin with selective biological effect |
-
1985
- 1985-05-29 HU HU852050A patent/HU197733B/hu not_active IP Right Cessation
-
1986
- 1986-05-20 IL IL78849A patent/IL78849A/xx not_active IP Right Cessation
- 1986-05-21 ZA ZA863801A patent/ZA863801B/xx unknown
- 1986-05-22 FI FI862159A patent/FI82690C/fi not_active IP Right Cessation
- 1986-05-27 CS CS863877A patent/CS261894B2/cs unknown
- 1986-05-28 PL PL1986259759A patent/PL148718B1/pl unknown
- 1986-05-28 GR GR861390A patent/GR861390B/el unknown
- 1986-05-28 JP JP61121394A patent/JPS61277650A/ja active Pending
- 1986-05-28 DD DD86290679A patent/DD244977A5/de not_active IP Right Cessation
- 1986-05-28 PT PT82657A patent/PT82657B/pt not_active IP Right Cessation
- 1986-05-28 DK DK249686A patent/DK249686A/da not_active Application Discontinuation
- 1986-05-28 EP EP19860107223 patent/EP0205969B1/de not_active Expired - Lifetime
- 1986-05-28 US US06/868,772 patent/US4735965A/en not_active Expired - Fee Related
- 1986-05-28 YU YU90986A patent/YU46169B/sh unknown
- 1986-05-28 DE DE8686107223T patent/DE3683192D1/de not_active Expired - Lifetime
- 1986-05-28 AU AU58001/86A patent/AU588761B2/en not_active Ceased
- 1986-05-28 NZ NZ216339A patent/NZ216339A/xx unknown
- 1986-05-28 NO NO862112A patent/NO171677C/no unknown
- 1986-05-28 AT AT86107223T patent/ATE71093T1/de not_active IP Right Cessation
- 1986-05-29 CN CN86103741A patent/CN1010587B/zh not_active Expired
- 1986-05-29 SU SU864027565A patent/SU1454250A3/ru active
- 1986-05-29 KR KR1019860004241A patent/KR860009031A/ko not_active Abandoned
- 1986-05-29 ES ES555454A patent/ES8706624A1/es not_active Expired
- 1986-09-18 SU SU864028148A patent/SU1447823A1/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU92004429A (ru) | Производные 2-(1-пиперазинил)-4-фенил-цикло-алканопиридина | |
| FI842760A0 (fi) | Menetelmä terapeuttisesti aktiivisten imidatsoliumyhdisteiden valmistamiseksi | |
| NO171461C (no) | Anvendelse av di-peroksydodekandisyreagglomerater som blekemiddel | |
| ATE16489T1 (de) | Aroylimidazolone. | |
| DE3477488D1 (en) | Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives | |
| ES539123A0 (es) | Un compuesto de 3-indolcarboxamida | |
| DK397383A (da) | 2-nitro-1,1-ethendiaminer, fremgangsmaader til fremstilling deraf samt deres anvendelse som laegemidler | |
| DK249686D0 (da) | Ephedrinsalte, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse forbindelser | |
| BE904656A (fr) | Ethers cyclopentyliques, leur preparation et formulations pharmaceutiques les contenant. | |
| KR860000269A (ko) | 칼슘길항성의 1-[비스-(4-플루오로페닐)-메틸-4-(3-페닐-2-프로페닐)-헥사하이드로-1h-1, 4-디아제핀의 제조방법및 이것을 함유한 약학적조성물 | |
| BE1002427A3 (fr) | Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament. | |
| NO167286C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater. | |
| ATE63541T1 (de) | N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel. | |
| SE8601799D0 (sv) | (-)-1beta-ethyl-1alfa-hydroxymethyl-1,2,3,4,6,7,12,12balfa-octahydroindolo/2,3-a/quinolizine, process for its preparation and pharmaceutical compositions containing same | |
| ATE91418T1 (de) | Mittel zur behandlung der herzinsuffizienz. | |
| BE904699A (fr) | Acides hydroxamiques de beta-lactames o-sulfates, leurs sels d'addition d'acide, ainsi que leur preparation et leur utilisation. | |
| FR2419935A1 (fr) | Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant | |
| BG60236B1 (bg) | Метод за получаване на цикличен пропиленов естер на дихидропиридин-5-фосфонова киселина | |
| FR2449680A1 (fr) | Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant | |
| DK438485A (da) | Fremgangsmaade til fremstilling af ranitidin eller syreadditionssalte deraf | |
| SE8300322D0 (sv) | Komplexsalt | |
| DE3778858D1 (de) | 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen. | |
| BG42833A3 (bg) | Метод за получаване на 1,3-бис/диметиламино/-2-пропил- 4-хлорфеноксиацетат |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |